Antibiotics: Global Anti-Infectives Markets Vol. II

1 Executive Summary
1.1 Scope and Objectives of the Report
1.2 Methodology
2 Introduction and Overview
2.1 Definition of Antibiotic Drugs
2.2 Classes of Antibiotic Drugs
2.3 Disease Conditions for Use
3 Issues and Trends in Antibiotics
3.1 Antibiotic Resistance
3.2 Emerging Disease Treatment Markets
3.3 Biodefense
4 Sulphonamides
4.1 Overview of Class
4.1.1 Mechanism of Action
4.1.2 Disease Conditions Treated
4.1.3 Adverse Event Profile
4.2 Global Market Analysis
4.2.1 Total World Market Size and Growth
4.2.2 U.S. Market Size and Growth
4.2.3 Western European Market Size and Growth
4.2.4 Japanese Market Size and Growth
4.2.5 Rest of World Market Size and Growth
4.3 Competitive Analysis
4.3.1 Leading Drugs
4.3.2 Leading Companies
5 Penicillins
5.1 Overview of Class
5.1.1 Mechanism of Action
5.1.2 Disease Conditions Treated
5.1.3 Adverse Event Profile
5.2 Global Market Analysis
5.2.1 Total World Market Size and Growth
5.2.2 U.S. Market Size and Growth
5.2.3 Western European Market Size and Growth
5.2.4 Japanese Market Size and Growth
5.2.5 Rest of World Market Size and Growth
5.3 Competitive Analysis
5.3.1 Leading Drugs
5.3.2 Leading Companies
6 Tetracyclines
6.1 Overview of Class
6.1.1 Mechanism of Action
6.1.2 Disease Conditions Treated
6.1.3 Adverse Event Profile
6.2 Global Market Analysis
6.2.1 Total World Market Size and Growth
6.2.2 U.S. Market Size and Growth
6.2.3 Western European Market Size and Growth
6.2.4 Japanese Market Size and Growth
6.2.5 Rest of World Market Size and Growth
6.3 Competitive Analysis
6.3.1 Leading Drugs
6.3.2 Leading Companies
7 Cephalosporins
7.1 Overview of Class
7.1.1 Mechanism of Action
7.1.2 Disease Conditions Treated
7.1.3 Adverse Event Profile
7.2 Global Market Analysis
7.2.1 Total World Market Size and Growth
7.2.2 U.S. Market Size and Growth
7.2.3 Western European Market Size and Growth
7.2.4 Japanese Market Size and Growth
7.2.5 Rest of World Market Size and Growth
7.3 Competitive Analysis
7.3.1 Leading Drugs
7.3.2 Leading Companies
8 Cephems
8.1 Overview of Class
8.1.1 Mechanism of Action
8.1.2 Disease Conditions Treated
8.1.3 Adverse Event Profile
8.2 Global Market Analysis
8.2.1 Total World Market Size and Growth
8.2.2 U.S. Market Size and Growth
8.2.3 Western European Market Size and Growth
8.2.4 Japanese Market Size and Growth
8.2.5 Rest of World Market Size and Growth
8.3 Competitive Analysis
8.3.1 Leading Drugs
8.3.2 Leading Companies
9 Aminoglycosides
9.1 Overview of Class
9.1.1 Mechanism of Action
9.1.2 Disease Conditions Treated
9.1.3 Adverse Event Profile
9.2 Global Market Analysis
9.2.1 Total World Market Size and Growth
9.2.2 U.S. Market Size and Growth
9.2.3 Western European Market Size and Growth
9.2.4 Japanese Market Size and Growth
9.2.5 Rest of World Market Size and Growth
9.3 Competitive Analysis
9.3.1 Leading Drugs
9.3.2 Leading Companies
10 Macrolides
10.1 Overview of Class
10.1.1 Mechanism of Action
10.1.2 Disease Conditions Treated
10.1.3 Adverse Event Profile
10.2 Global Market Analysis
10.2.1 Total World Market Size and Growth
10.2.2 U.S. Market Size and Growth
10.2.3 Western European Market Size and Growth
10.2.4 Japanese Market Size and Growth
10.2.5 Rest of World Market Size and Growth
10.3 Competitive Analysis
10.3.1 Leading Drugs
10.3.2 Leading Companies
11 Glycopeptides
11.1 Overview of Class
11.1.1 Mechanism of Action
11.1.2 Disease Conditions Treated
11.1.3 Adverse Event Profile
11.2 Global Market Analysis
11.2.1 Total World Market Size and Growth
11.2.2 U.S. Market Size and Growth
11.2.3 Western European Market Size and Growth
11.2.4 Japanese Market Size and Growth
11.2.5 Rest of World Market Size and Growth
11.3 Competitive Analysis
11.3.1 Leading Drugs
11.3.2 Leading Companies
12 Quinolones
12.1 Overview of Class
12.1.1 Mechanism of Action
12.1.2 Disease Conditions Treated
12.1.3 Adverse Event Profile
12.2 Global Market Analysis
12.2.1 Total World Market Size and Growth
12.2.2 U.S. Market Size and Growth
12.2.3 Western European Market Size and Growth
12.2.4 Japanese Market Size and Growth
12.2.5 Rest of World Market Size and Growth
12.3 Competitive Analysis
12.3.1 Leading Drugs
12.3.2 Leading Companies
13 Carbapenems
13.1 Overview of Class
13.1.1 Mechanism of Action
13.1.2 Disease Conditions Treated
13.1.3 Adverse Event Profile
13.2 Global Market Analysis
13.2.1 Total World Market Size and Growth
13.2.2 U.S. Market Size and Growth
13.2.3 Western European Market Size and Growth
13.2.4 Japanese Market Size and Growth
13.2.5 Rest of World Market Size and Growth
13.3 Competitive Analysis
13.3.1 Leading Drugs
13.3.2 Leading Companies
14 Oxazolidinones
14.1 Overview of Class
14.1.1 Mechanism of Action
14.1.2 Disease Conditions Treated
14.1.3 Adverse Event Profile
14.2 Global Market Analysis
14.2.1 Total World Market Size and Growth
14.2.2 U.S. Market Size and Growth
14.2.3 Western European Market Size and Growth
14.2.4 Japanese Market Size and Growth
14.2.5 Rest of World Market Size and Growth
14.3 Competitive Analysis
14.3.1 Leading Drugs
14.3.2 Leading Companies
15 Streptogramins
15.1 Overview of Class
15.1.1 Mechanism of Action
15.1.2 Disease Conditions Treated
15.1.3 Adverse Event Profile
15.2 Global Market Analysis
15.2.1 Total World Market Size and Growth
15.2.2 U.S. Market Size and Growth
15.2.3 Western European Market Size and Growth
15.2.4 Japanese Market Size and Growth
15.2.5 Rest of World Market Size and Growth
15.3 Competitive Analysis
15.3.1 Leading Drugs
15.3.2 Leading Companies
16 Other: Rifampin, Clindamycin, Etc.
16.1 Overview of Other Antibiotics
16.1.1 Rifampin
16.1.2 Clindamycin
16.2 Global Market Analysis
16.2.1 Total World Market Size and Growth
16.2.2 U.S. Market Size and Growth
16.2.3 Western European Market Size and Growth
16.2.4 Japanese Market Size and Growth
16.2.5 Rest of World Market Size and Growth
16.3 Competitor Analysis
16.3.1 Leading Drugs
16.3.2 Leading Competitors
17 Overall Market Summary
17.1 Total World Market Projection
17.2 World Market Projections by Antibiotic Class
17.3 World Market Projections by Geographic Region
18 Research Activities
18.1 Peptide Antibiotics
18.2 Bacteriophages
18.3 Iron Absorption Mimicry
19 Company Briefs
19.1 Advancis Pharmaceutical Corp.
19.2 Alcon Laboratories, Inc
19.3 Cubist Pharmaceuticals, Inc.
19.4 Bayer Corp.
19.5 Kyorin Pharmaceutical Co., Ltd
19.6 Daiichi Pharmaceutical Co., Ltd.
19.7 Eli Lilly and Co.
19.8 LG Life Sciences, Ltd
19.9 Micrologix Biotech Inc.
19.10 Novartis AG
19.11 Pfizer Inc.
19.12 Pliva d.d
19.13 Ranbaxy Laboratories Ltd.
19.14 Toyama Chemical Co., Ltd.
19.15 Wyeth